Project Grant R35GM155085

Award Date 7/1/24
Completion Date 4/30/29
Dollars Obligated $1.2M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
This $1,220,400 Project Grant awarded by the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences supports a collaborative research project between investigators in the U.S. and U.K. to better understand the regulatory mechanisms controlling mammalian gene expression. The project, funded through NSF's Biological Sciences program (CFDA 47.074), aims to define the roles of different DNA regulatory elements and how they work together to precisely control gene expression....
This $240,000 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) funds a postdoctoral research fellowship to investigate the role of genome organization on de novo gene origination. The research aims to test a new theoretical model explaining the process of new gene evolution, by examining how the genome's structural features influence the birth of genes that arise from non-coding regions. The key components of the research include: 1)...
The National Institute of General Medical Sciences (NIGMS) awarded a $415,252 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of California, Berkeley (UC Berkeley) for the project "PHYSICAL BIOLOGY OF TRANSCRIPTIONAL CONTROL IN EMBRYONIC DEVELOPMENT". The overarching goal is to leverage knowledge about regulatory regions and transcription factors to develop a predictive understanding of the developmental program...
This federal Project Grant award of $491,739 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to determine the detailed molecular mechanisms underlying the evolution of transcriptional circuits in unicellular yeasts. The research aims to uncover specific examples of transcriptional rewiring and reveal the mechanisms by which these changes occur, which can contribute to biological novelty. The...
The National Institute of General Medical Sciences (NIGMS) awarded a $395,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Utah State University (USU) to investigate the role of structural variants in trait variation and adaptive evolution across three insect systems: Timema stick insects, Callosobruchus maculatus seed beetles, and Lycaeides butterflies. The 5-year project, starting on May 1, 2025, will combine genome assemblies, population genomic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 - Biomedical Research and Research Training, aims to advance the understanding of how homeodomain (HD) transcription factors (TFs) regulate gene expression and impact human health. The $510,390 award to the Children's Hospital Medical Center in Cincinnati, Ohio will fund a 5-year research program to investigate the mechanisms underlying HD TF DNA binding specificity, the functional impact...
This Project Grant from the National Science Foundation, under the Biological Sciences program (CFDA 47.074), provides $240,000 to fund research investigating gene regulatory network evolution across 13 species of roundworms. The fellowship award supports a postdoctoral researcher from June 1, 2023 to May 31, 2026. The researcher will use single-cell sequencing to build molecular atlases of embryonic development for each roundworm species, comparing gene expression patterns across tissues and...
This $1,166,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to understand how evolutionary processes, especially natural selection, shape patterns of genetic variation across genomes. The key products and services to be delivered under this 5-year grant, awarded on August 16, 2024, include: Generating better estimates of the genome-wide fitness effects of new mutations, as...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,507,500.00 to Yale University to conduct research on the regulatory mechanisms by which the genome encodes non-genetic heterogeneity in cell systems. The project aims to identify transcription factor pairs that drive transcriptional heterogeneity, determine heritable memory loci capable of transmitting non-genetic heterogeneity across...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $328,117 to the University of California, San Diego (UC San Diego) to conduct research on the genetic basis of neural cell type evolution in insect retinas. The project aims to use the insect visual system as a model to understand how changes in gene regulatory networks and genome sequences lead to the evolution of diverse neural cell types. Key focus areas include...

THE GENETIC AND EVOLUTIONARY MECHANISMS UNDERLYING THE ORIGINS OF NEW MOLECULARFUNCTIONS - SUMMARY THE MOLECULAR BASIS BY WHICH A NEW FUNCTION EMERGES IN EVOLUTION SETS THE MECHANISMS BY WHICH IT CAN BREAK DOWN - ULTIMATELY CONTRIBUTING TO DISEASE. UNFORTUNATELY, OUR UNDERSTANDING OF THE GENETIC, MOLECULAR, AND EVOLUTIONARY MECHANISMS RESPONSIBLE FOR THE ORIGINS OF NEW FUNCTIONS IS LIMITED BECAUSE MOST FUNCTIONS EVOLVED ONLY ONCE IN THE DISTANT PAST AND HAVE BEEN MODIFIED BY SUBSEQUENT EVOLUTIONARY PROCESSES. IN PARTICULAR, CHANGES IN GENE REGULATION ARE A COMMON ROUTE BY WHICH NEW MOLECULAR FUNCTIONS OCCUR, ACCOUNT FOR MUCH OF THE VARIATION IN COMPLEX TRAITS, AND PLAY IMPORTANT ROLES IN HUMAN HEALTH AND DISEASE. HOWEVER, FUNDAMENTAL QUESTIONS ABOUT THE EVOLUTION OF GENE REGULATION REMAIN UNKNOWN. FIRST, WE OFTEN DO NOT KNOW THE GENES RESPONSIBLE FOR REGULATORY CHANGES. THIS IS IN LARGE PART BECAUSE WE LACK SYSTEMS AND TOOLS WHERE THE GENETIC BASIS OF REGULATORY DIFFERENCES CAN BE DETERMINED BETWEEN SPECIES. SECOND, WHILE TRANSCRIPTION FACTORS PLAY KEY ROLES IN GENE REGULATION AND CHANGES IN THEM CAN BE SOURCES OF DISEASE, WE LACK APPROACHES FOR DETERMINING WHETHER THEY PLAY KEY ROLES IN THE EVOLUTION OF GENE REGULATION. FURTHERMORE, IF TRANSCRIPTION FACTORS ARE IMPORTANT SOURCES OF REGULATORY VARIATION, THE MOLECULAR MECHANISMS BY WHICH PLEIOTROPIC CONSEQUENCES ARE AVOIDED ARE POORLY UNDERSTOOD. THIRD, CORRECT GENE REGULATION IS ESSENTIAL, YET DIFFERENCES IN REGULATION ARE QUITE COMMON. DESPITE THIS, THE RATE OF REGULATORY CHANGE AND THE EVOLUTIONARY MECHANISMS RESPONSIBLE ARE NOT KNOWN BECAUSE WE LACK SYSTEMS WHERE THESE CAN BE DISSECTED INTO THE INDIVIDUAL MOLECULAR CHANGES THAT OCCURRED. OVER THE NEXT FIVE YEARS, MY RESEARCH GROUP WILL ADDRESS THESE KNOWLEDGE GAPS USING HIGH- THROUGHPUT APPROACHES IN THE SACCHAROMYCES YEAST. DESPITE BEING AS GENETICALLY DISTINCT AS HUMANS AND BIRDS, SPECIES IN THE SACCHAROMYCES GENUS NATURALLY PRODUCE VIABLE HYBRIDS AND CAN BE GENETICALLY CROSSED AFTER PRECISE GENOME ENGINEERING. WE WILL USE THIS ABILITY TO DEVELOP A SYSTEM FOR MAPPING THE GENETIC BASIS OF REGULATORY DIFFERENCES ON LONG EVOLUTIONARY TIMESCALES. THIS WILL REVEAL COMMON GENETIC SOURCES OF REGULATORY DIVERGENCE, AS WELL AS THE BROAD MOLECULAR BASIS BY WHICH REGULATORY EVOLUTION OCCURS. SACCHAROMYCES YEAST ALSO CONTAIN ALL COMMON MECHANISMS OF TRANSCRIPTION FACTOR BINDING FOUND AMONG EUKARYOTES. WE WILL DEVELOP HIGH- THROUGHPUT AND UNBIASED APPROACHES FOR DETERMINING HOW IMPORTANT CHANGES IN THESE TRANSCRIPTION FACTORS HAVE BEEN IN REGULATORY EVOLUTION. FINALLY, WE WILL DETERMINE THE RATE OF REGULATORY CHANGE AND THE MOLECULAR BASIS FOR COMPENSATORY CHANGES IN GENE REGULATION. THE LONG-TERM GOAL OF THIS WORK IS TO IMPROVE OUR UNDERSTANDING OF HOW GENE REGULATION FUNCTIONS AND EVOLVES TO IMPROVE OUR ABILITY TO PREDICT THE EFFECTS OF REGULATORY VARIATION IN HEALTH AND DISEASE.

Posted 6/26/24, 12:00 AM